Introduction {#sec0005}
============

Respiratory syncytial virus (RSV) is one of the major causes of pediatric respiratory tract infections \[[@bib0005]\]. RSV is estimated to cause approximately 30.5 million annual cases among infants less than one, of which 3.3 million require hospitalization \[[@bib0005]\]. We have recently shown that RSV accounts for 16% of influenza-like illnesses in Lebanon, where children under the age of 2 years were at the highest risk for infection \[[@bib0010]\]. Recurrent infections later in life are inevitable and are usually asymptomatic or accompanied by mild symptoms \[[@bib0015]\].

RSV is an enveloped *Pneumovirus* belonging to the *Paramyxoviridae* family with a linear, non-segmented, single-stranded, (−) sense RNA genome coding for 11 viral proteins \[[@bib0020]\]. The two envelop proteins, glycoproteins G and fusion protein F constitute the viral antigens that trigger the humoral and cellular immune response of the host \[[@bib0025]\]. The G protein mediates attachment of RSV to its host cell, while the F protein triggers the fusion of the viral envelop with the cell plasma membrane during viral penetration. Moreover, the F protein mediates the fusion between neighboring cells resulting in syncytia formation, which is the most common method of virus propagation \[[@bib0025]\].

RSV infection starts as a mild upper respiratory tract infection \[[@bib0030],[@bib0035]\]. However, the infection can progress to lower respiratory tract infection, characterized by severe symptoms and pathogenesis such as epithelial cell necrosis, sloughing of desquamated cells into the bronchiolar lumen, submucosal and adventitial tissue edema as well as accumulation of macrophages and neutrophils in the peribronchiolar and perivascular regions \[[@bib0040]\]. Besides, excessive mucus secretion and syncytia formation represent the main hallmarks of RSV infection \[[@bib0040],[@bib0045]\]. Excessive mucus secretion upon RSV infection leads to the formation of mucus plugs, pulmonary obstruction, and shortness of breath \[[@bib0050]\].

Most of the data currently available on RSV are from studies in monolayer (2D) cultures. 2D cell culture models lack the complex biological processes that occur *in vivo*; therefore, the pathogenesis of RSV in these flat models may not be representative of what happens *in vivo* \[[@bib0055],[@bib0060]\]. Studies have demonstrated that cells undergo different biologic responses when grown in 3D compared with 2D settings \[[@bib0065],[@bib0070]\]. They can differ in their morphology, with an altered cytoskeletal organization and cell adhesion. Other changes include different proliferation rates, signaling processes and differentiation potential. Many of these differences are believed to result from the fact that cells grown as monolayers on flat plastic surfaces are not subjected to the cell--cell and cell--matrix interactions, soluble factors, matrix composition and stiffness, oxygen and nutrient gradients, protein concentration gradients and mechanical stresses, as they would in their source tissues \[[@bib0050]\].

Since the early 2000s, an increasing number of evidence emerged about 3D cell cultures remarkably recapitulating the host cell response to microbial infections *in vivo* \[[@bib0075], [@bib0080], [@bib0085]\]. 3D cultures have been successful in studying various viruses and were the first definitive model for human norovirus and hepatitis C virus; however, to date, there are no reports to investigate RSV growth and pathogenesis in 3D cultures \[[@bib0085], [@bib0090], [@bib0095]\]. In this study, a scaffold-free 3D culture system was adopted using ultra-low attachment (ULA) plates to generate a practical and economic A549 spheroids model and test its permissiveness to RSV.

Materials and methods {#sec0010}
=====================

Cell culture {#sec0015}
------------

African green monkey kidney cells (Vero cells, ATCC CCL-81), human Alveolar epithelial type II cells (A549; ATCC CCL-185) and human laryngeal carcinoma cells (Hep2 cells, ATCC CCL-23, a kind gift from Dr. Ralph Tripp, University of Georgia) were cultured in Dulbecco modified Eagle medium-high glucose (DMEM, D5796-Sigma) supplemented with 10% fetal bovine serum (F9665-Sigma) and 1% of 100 U/ml penicillin/streptomycin (pen/strep, MS006W100N Biowest) and maintained in 5% CO~2~ at 37 °C.

A549 spheroid formation {#sec0020}
-----------------------

A549 cells cultured in monolayers were dissociated and suspended in complete medium containing 0.25% methylcellulose (M0512-Sigma) as a thickening agent \[[@bib0100]\]. Seeding densities of 10 × 10^3^, 25 × 10^3^ or 50 × 10^3^ cells were prepared in 200 μl of the 0.25% methylcellulose nutritive medium and seeded in 96-well round-bottom ultra-low attachment (ULA) plates (7007 Corning). Each well forms a single spheroid whose size varies depending on the initial cell seeding density. The cells were then incubated for seven days with media change every other day for the duration of the experiment.

Spheroid viability {#sec0025}
------------------

A549 Spheroids' growth and viability were assessed on days 3, 5, and 7 post-seeding. The culture media was aspirated, and spheroids were washed with 1X PBS (D1408-500 ml Sigma). The spheroids were dissociated into single-cell suspensions by treatment with 0.25% trypsin/ EDTA (T4049-500 ml Sigma) for 15 min, followed by gentle pipetting. Then complete media was added, and the single-cell suspensions of the corresponding spheroids were centrifuged at 1100 RPM for 5 min. The cell pellets were resuspended in 300 μl of 1:1 mixture of complete media and trypan blue (T8154-100 ml Sigma). Viable cell count was determined using a hemocytometer. Alternatively, the cell pellets were resuspended in a 0.02 μM calcein-AM solution (C3099 Life Technologies) and incubated at room temperature for 20 min in the dark. Following incubation, the cells were pelleted, resuspended in 800 μl of PBS and passed through the Guava EasyCyte8 Flow Cytometer. A total of 5000 live events were excited at 488 nm per sample and measured for green fluorescence at 530 nm. Gating analysis was performed using FlowJo (FlowJo LLC) cytometry analysis software and a representative density-plot graph was shown.

Virus propagation and titration {#sec0030}
-------------------------------

Vero cells were used for virus propagation. These cells were inoculated with human RSV subgroup A (RSVA 2001/2--20, IRR) at 0.5 multiplicity of infection (MOI). The virus was then harvested upon extensive syncytia formation (5--8 days) by a single freeze-thaw lysis cycle followed by centrifugation and collection of the supernatant. The virus stock was quantified by using plaque assay. In brief, Hep2 cells seeded on a 6-well plate were inoculated with 200 μl of 10-fold serial dilutions of the virus stock for 2 h with gentle shaking every 15 min. Afterward, the cells were covered with 2 ml of newly prepared 0.15% agarose nutritive overlay and incubated for 7 days. Plaques were visualized by staining the cells with a crystal violet solution containing 5% formaldehyde.

Infectivity and growth kinetics of RSV in 3D spheroids {#sec0035}
------------------------------------------------------

Three-day-old A549 spheroids were inoculated using RSV at a MOI = 1 (in a volume of 20 μl) and incubated for 2 h to allow virus adsorption. The inoculum was then removed and the spheroids were washed with DMEM and incubated for 7 days in 200 μl of DMEM containing 5% FBS and 1% pen/strep. Plaque assay was used to assess the spheroids' infectious virus yield at days 1, 3, 5 and 7 post-inoculation. At each time point, five spheroids were pooled with their supernatant, broken down into cell suspensions by vigorous pipetting and cells lysed by flash freezing to ensure the release of virions from the cells. The resulting cell lysate was then centrifuged and the plaque assay was performed on the supernatant as shown above to determine the viral yield in terms of plaque forming units (pfu) per milliliter (ml).

Immunofluorescent staining of spheroids {#sec0040}
---------------------------------------

After 3 and 7 days post-inoculation, spheroids were fixed with 4% paraformaldehyde (416785000 ACROS) for 15 min and permeabilized with 0.2% Triton X-100 (T9284-100 ml Sigma) in PBS for 20 min. Spheroids were blocked with blocking solution \[1% BSA (A3912-100 g Sigma) and 0.1% Triton X-100 in PBS\] for 1 h followed by overnight incubation with a mixture of mouse anti-RSV fusion protein antibody (MAB8599-Merck Millipore) at 1:200 and rabbit anti-human MUC1 antibody (12123-T24 Sino Biological) at 1:2500 in blocking buffer. The samples were then thoroughly washed with PBS/Tween (0.1%) (BP337-500-Fisher BioReagents) and incubated for 1 h with the corresponding fluorescent secondary antibodies (1:250) \[Alexa fluor 488-goat anti-mouse IgG antibody (A11002-Life Technologies) and Alexa fluor 594-donkey anti-rabbit IgG antibody (A21207-Life Technologies)\]. Finally, the immunostained spheroids were mounted with the Fluoroshield with DAPI histology mounting medium (F6057-Sigma), before being visualized by the LSM710 laser scanning confocal microscope (Zeiss). The fluorescence intensities of MUC1 and RSV-F captured on the images were quantified by employing ZEN blue edition (Zeiss) and presented as fold change values in infected spheroids as compared to their time matching controls.

Statistical analysis {#sec0045}
--------------------

All experiments were done at least two times in triplicates (unless otherwise indicated) and the data were presented as mean ± SD. The statistical significance of differences between groups was performed by Student's t-test using SPSS statistical software version 24 (SPSS, Inc., Chicago, IL, USA). A P-value \<0.05 was considered to indicate a statistically significant difference.

Results {#sec0050}
=======

Generation of A549 spheroids using ultra-low attachment (ULA) plates {#sec0055}
--------------------------------------------------------------------

Three starting cell-seeding densities were used; namely, 10 × 10^3^, 25 × 10^3^, and 50 × 10^3^ cells/well in 96 well, ultra-low attachment (ULA) plates ([Fig. 1](#fig0005){ref-type="fig"} A), and the resulting spheroids were followed up until day 7 in culture. Well-formed spheroids were visible for the 25 × 10^3^ and 50 × 10^3^ cell seeding densities at day 3 post-seeding, becoming more compact on day 7 ([Fig. 1](#fig0005){ref-type="fig"}B). However, the 10 × 10^3^ cell seeding density failed to produce well-formed spheroids even after 7 days of incubation and therefore were abandoned.Fig. 1Morphology and viability of A549 spheroids in U-bottom, 96-well ULA plates. (1A**)** Schematic diagram of spheroid assembly. (1B) Phase-contrast optical micrographs showing A549 spheroids morphology at an initial seeding density of 25 × 10^3^ and 50 × 10^3^ cells/well after 3 and 7 days of culture. (1C) Influence of culture time on the viability of A549 spheroids at a seeding density of 25 × 10^3^ cells/well (black bars) and 50 × 10^3^ cells/well (grey bars). At days 3, 5, and 7 post-seeding, spheroids were dissociated, stained with trypan blue, and counted under the microscope using a hemocytometer. 25 × 10^3^ A549 spheroids reveal significantly higher viability than the 50 × 10^3^ A549 spheroids at all time-points. Error bars represent ± SD (n = 6). \**p* \< 0.05, \*\* *p* \< 0.01.Fig. 1

The cell count and viability of spheroids were assessed using trypan blue exclusion assay ([Fig. 1](#fig0005){ref-type="fig"}C). Three days post-seeding, the 25 × 10^3^ spheroids grew to reach ∼33 × 10^3^ viable cells (86% viability). The 50 × 10^3^ cell spheroids contained 37 × 10^3^ viable cells (78% viability). Throughout the 7 days, the 25 × 10^3^ cell spheroids maintained a constant viable cell count of ∼33 × 10^3^ cells, although their viability gradually yet significantly decreased, reaching 65% by day 7 ([Fig. 1](#fig0005){ref-type="fig"}C). As for the 50 × 10^3^ cell spheroids, a gradual and significant decline in viability was recorded throughout the 7 days. The viable cell count significantly dropped to 18 × 10^3^ cells only by day 7 with 56% viability. Comparative viability analysis of the 25 × 10^3^ and 50 × 10^3^ cell spheroids showed significantly lower viability of the bigger spheroids than the smaller ones. Therefore, the 25 × 10^3^A549 spheroids were adopted for the rest of the study.

The viability profile of 25 × 10^3^ cell spheroids was further validated using flow cytometry. Similar to the data obtained by using trypan blue, we observed a steady time-dependent decline in the viability of the spheroids between days 3 to 7, where the healthy population dropped from 94.4% to 77.5%, respectively ([Fig. 2](#fig0010){ref-type="fig"} ).Fig. 2Flow cytometry analysis of 25 × 10^3^ A549 spheroids. Spheroids were cultured for 3, 5, and 7 days, then dissociated into single-cell suspensions, stained with 0.02 μM calcein-AM, and underwent flow cytometry at 488 nm excitation (n = 3). Density plots displaying calcein-AM florescent cells *versus* side scatter (SSC) illustrated 94.4% viability at day 3 (2A), 80.4 % viability at day 5 (2B) and 77.5 % viability at day 7 (2C). The analysis was performed by Flow Jo software.Fig. 2

RSV infection of A549 spheroids {#sec0060}
-------------------------------

We next sought to determine if the A549 spheroids are susceptible and permissive for RSV infection. As such, 3-day-old spheroids were inoculated with RSV (1 MOI) and immunostained at days 3 and 7 post-inoculation ([Fig. 3](#fig0015){ref-type="fig"} ). A prominent RSV-F protein staining was noted at day 3 post-inoculation ([Fig. 3](#fig0015){ref-type="fig"}A) that disseminated towards the core of the spheroid by day 7 post-inoculation ([Fig. 3](#fig0015){ref-type="fig"}B). Mild syncytia formation induced by RSV infection was also noted at the spheroid rim at 3 days post-inoculation ([Fig. 3](#fig0015){ref-type="fig"}A insets). The intensity of RSV-F protein staining increased by 2-fold on day 7 compared to day 3 post-inoculation ([Fig. 3](#fig0015){ref-type="fig"}C). These findings indicate that the virus has effectively infected the spheroids spreading towards its center throughout infection. Additionally, a 2.6-fold increase in MUC1 expression was noted in the spheroids on day 3 post-infection compared to mock (uninfected). MUC1 production further increased, reaching 3.25-fold at day 7 post-inoculation relative to mock ([Fig. 3](#fig0015){ref-type="fig"}D). These results are indicative of a progressive infection established in the form of virus dissemination within the spheroids and gradual mucin accumulation, a hallmark of RSV infection.Fig. 3RSVA infection and mucin production in A549 spheroids. A549 Spheroids were inoculated with 1 MOI of RSVA 2001/2-20 and incubated for 3 (3A) and 7 (3B**)** days. At the assigned time-points, spheroids were immunostained with anti-RSV F antibody (green), anti-MUC1 antibody (red), and counterstained with the nuclear stain DAPI (blue) and visualized by confocal microscopy at 10× magnification (n = 3). Syncytial formation in RSV infected spheroids at day 3 post-infection was also shown in insets at 40× magnification. (3C) Mucin accumulation and (3D) RSV-F dissemination were measured by the Zeiss LSM710 laser scanning confocal microscope. Mucin intensity fold change was evaluated between infected spheroids and their time matching controls (n = 3). RSV-F intensity fold change was evaluated between day 3 and day 7 infected spheroids (n = 3). Error bars represent ± SD (n = 3). \**p* \< 0.05, \*\* *p* \< 0.01, \*\*\**p* \< 0.001.Fig. 3

After establishing and demonstrating successful infection of spheroids with RSV, plaque assay was performed to investigate growth kinetics of RSV in spheroids after 1, 3, 5, and 7 days of infection ([Fig. 4](#fig0020){ref-type="fig"} ). The data revealed productive viral replication in the spheroids, yielding 5.25 log~10~ PFU/ml unit at day 1 post-inoculation. The virus yield slightly dropped from 4.93 log~10~ at day 3 and reaching 4 log~10~ PFU/ml on days 5 and 7 post-inoculation, suggesting that spheroids are capable of sustaining infection for up to 7 days post-inoculation.Fig. 4Growth kinetics of RSVA in A549 spheroids. Spheroids were inoculated with 1 MOI of RSVA and incubated for 7 days. At each of the assigned time-points, 5 infected spheroids were pooled, broken down into cell suspensions, and flash frozen. Virus yield was determined by using plaque assay of the supernatants and cell lysate suspensions at days 1, 3, 5, and 7 post-inoculation. Error bars represent ± SD (n = 3). \**p* \< 0.05.Fig. 4

Discussion {#sec0065}
==========

Animal models have been routinely used to study RSV-induced respiratory diseases; even though useful, they do not fully mimic viral pathogenesis *in vivo* \[[@bib0105], [@bib0110], [@bib0115], [@bib0120], [@bib0125], [@bib0130]\]. This can be attributable to the molecular, cellular, and physiological differences between animals and humans. 3D culture techniques have been used for many years in a wide variety of biomedical applications ranging from cancer and stem cell biology to tissue engineering and regenerative medicine \[[@bib0085],[@bib0135], [@bib0140], [@bib0145], [@bib0150], [@bib0155], [@bib0160]\]. 3D cultures promote direct cell-cell contact, interactions of cells with the extracellular matrix (ECM), and *in vivo*-like exchange of soluble factors, thus allowing cells to more closely resemble the *in vivo* parental tissue as opposed to their 2D monolayer counterparts \[[@bib0065], [@bib0070], [@bib0075]\]. Despite their success, the use of 3D technology in studying microbial infections is still in its infancy.

3D culture models have well demonstrated utility for studying bacterial and viral pathogens. Previous studies revealed that spheroids are more representative models for *Pseudomonas aeruginosa* and *Salmonella enterica* compared to monolayer cultures in terms of invasiveness, histopathology, and immunopathology \[[@bib0165],[@bib0170]\]. Cells grown in spheroids were also shown to be the first definitive model for human norovirus \[[@bib0090]\] and hepatitis C virus studies \[[@bib0095]\], which lacked a suitable cell culture and murine study models. These viruses were capable of replicating and triggering a cytopathic effect in the 3D spheroid. Moreover, influenza virus, human immunodeficiency virus (HIV), and coronavirus have all been successfully studied in 3D cultures \[[@bib0085]\]. Recently, Zou et al. \[[@bib0175]\] developed human adult stem cell (ASC)-derived airway 3D that can be utilized to assess infectivity of emerging influenza viruses to human. Another work by Imle and colleagues introduced a 3D culture of primary human CD4 T lymphocytes as an *ex vivo* model system to study HIV-1 in tissue-like microenvironments \[[@bib0180]\]. Here, we established a simple and economic 3D spheroid culture of alveolar type II epithelial cells (A549) as a model to study RSV infection. This culture model can provide a tool for investigating the cellular and molecular mechanisms underlying RSV pathogenesis and to potentially test the effectiveness of antiviral molecules.

Syncytia formation and excessive mucin (MUC1) production are the hallmarks of RSV infection *in vivo* \[[@bib0040],[@bib0045]\]. *In vitro*, when A549 monolayers were infected with RSV, MUC1 secretion was only recorded for up to 3 days, after which it started to decline \[[@bib0185],[@bib0190]\]. Contrary, studies performed on monolayers of primary human airway epithelial cells report syncytium formation and increased mucin production for up to 6 days post-infection \[[@bib0195], [@bib0200], [@bib0205]\]. Our results showed that A549 cells grown in spheroids are susceptible and permissive of RSV, which disseminated to the center of the spheroids and induced excessive mucin secretion for up to 7 days post-infection accompanied with syncytia formation. This shows that A549 cells in spheroids behave more closely to primary cells than to A549 monolayers in terms of mucin production and syncytia formation upon RSV infection. Furthermore, we showed that the infection was productive up to day 7 post-inoculation with the virus progressively spreading towards the center of the spheroid. Notably, the virus yield dropped on day by one log~10~ pfu/ml, which could be explained by the cell death happening at the core of the spheroids. Overall, our data clearly show that A549 spheroids constitute a promising model of RSV infection studies.

To our knowledge, this is the first study to develop a 3D culture model for RSV using alveolar epithelial type II cells and show that infected spheroids display some of the key features of RSV infection *in vivo*, *i.e.*, mucin secretion. Therefore, 3D cultures might be a promising *in vitro* model candidate for studying RSV that can bridge the gap between monolayers and *in vivo* models due to its permissiveness, sustainability of RSV infection, and its ability to recapitulate the lung epithelial tissue's response to infection. More importantly, they are cheap and simple to generate. However, this model is not without its limitations such as the lack of vasculature, tissue heterogeneity and fluid flows observed *in vivo*. Therefore, more work is required to make these 3D cultures ideal model systems to study virus-host interactions and maximize their translational utility.
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